DOCETAXEL (TXT) GIVEN EVERY 2 WEEKS IN PATIENTS WITH PRETREATED NON-SMALL CELL LUNG CANCER (NSCLC): A MONO-INSTITUTIONAL PHASE II STUDY


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles